106 related articles for article (PubMed ID: 12592340)
1. Telomere dynamics in childhood leukemia and solid tumors: a follow-up study.
Franco S; Ozkaynak MF; Sandoval C; Tugal O; Jayabose S; Engelhardt M; Moore MA
Leukemia; 2003 Feb; 17(2):401-10. PubMed ID: 12592340
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy.
Engelhardt M; Ozkaynak MF; Drullinsky P; Sandoval C; Tugal O; Jayabose S; Moore MA
Leukemia; 1998 Jan; 12(1):13-24. PubMed ID: 9436916
[TBL] [Abstract][Full Text] [Related]
3. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
5. Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase.
Nowak T; Januszkiewicz D; Zawada M; Pernak M; Lewandowski K; Rembowska J; Nowicka K; Mankowski P; Nowak J
Oncol Rep; 2006 Aug; 16(2):301-5. PubMed ID: 16820907
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of telomerase activity levels in acute leukemia.
Ohyashiki JH; Ohyashiki K; Iwama H; Hayashi S; Toyama K; Shay JW
Clin Cancer Res; 1997 Apr; 3(4):619-25. PubMed ID: 9815729
[TBL] [Abstract][Full Text] [Related]
7. Telomeres and telomerase in normal and leukemic hematopoietic cells.
Engelhardt M; Wäsch R; Guo Y
Leuk Res; 2004 Oct; 28(10):1001-4. PubMed ID: 15289009
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity and expression and telomere analysis in situ in the course of treatment of childhood leukemias.
Maláska J; Sklenicková M; Krejcí K; Fajkusová L; Bajer M; Hrstková H; Fajkus J
Blood Cells Mol Dis; 2000 Oct; 26(5):534-9. PubMed ID: 11112386
[TBL] [Abstract][Full Text] [Related]
9. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
10. Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias.
Capraro V; Zane L; Poncet D; Perol D; Galia P; Preudhomme C; Bonnefoy-Berard N; Gilson E; Thomas X; El-Hamri M; Chelghoun Y; Michallet M; Wattel E; Mortreux F; Sibon D
Exp Hematol; 2011 Feb; 39(2):195-202.e2. PubMed ID: 21056083
[TBL] [Abstract][Full Text] [Related]
11. Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
Gessner A; Thomas M; Castro PG; Büchler L; Scholz A; Brümmendorf TH; Soria NM; Vormoor J; Greil J; Heidenreich O
Leukemia; 2010 Oct; 24(10):1751-9. PubMed ID: 20686504
[TBL] [Abstract][Full Text] [Related]
12. [Studies of hTERT gene expression in acute leukemia children].
Li X; Wang X; Li X; Liu B; Zhang Y; Liao Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):486-8. PubMed ID: 12910697
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of telomerase activity and telomere length in acute myelogenous leukemia].
Liu L; Sun B; Liang Y
Zhonghua Xue Ye Xue Za Zhi; 2001 Nov; 22(11):592-4. PubMed ID: 11855149
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia.
Eskandari E; Hashemi M; Naderi M; Bahari G; Safdari V; Taheri M
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1515-1521. PubMed ID: 29936725
[TBL] [Abstract][Full Text] [Related]
15. Telomere biology of pediatric cancer.
Tabori U; Dome JS
Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
[TBL] [Abstract][Full Text] [Related]
16. Significant telomere shortening in childhood leukemia.
Adamson DJ; King DJ; Haites NE
Cancer Genet Cytogenet; 1992 Jul; 61(2):204-6. PubMed ID: 1638505
[TBL] [Abstract][Full Text] [Related]
17. Telomeres and telomerase in leukaemia and lymphoma.
Davison GM
Transfus Apher Sci; 2007 Aug; 37(1):43-7. PubMed ID: 17766184
[TBL] [Abstract][Full Text] [Related]
18. Telomere length shortening of peripheral blood mononuclear cells in solid-cancer patients undergoing standard-dose chemotherapy might be correlated with good treatment response and neutropenia severity.
Yoon SY; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Acta Haematol; 2007; 118(1):30-7. PubMed ID: 17429195
[TBL] [Abstract][Full Text] [Related]
19. A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia.
Sumi M; Tauchi T; Sashida G; Nakajima A; Gotoh A; Shin-Ya K; Ohyashiki JH; Ohyashiki K
Int J Oncol; 2004 Jun; 24(6):1481-7. PubMed ID: 15138591
[TBL] [Abstract][Full Text] [Related]
20. Telomeres and telomerase in hematologic neoplasia.
Ohyashiki JH; Sashida G; Tauchi T; Ohyashiki K
Oncogene; 2002 Jan; 21(4):680-7. PubMed ID: 11850796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
